Skip to content
Vital Connect

Zimbabwe Declines ‘Lopsided’ US Health Aid Package Because of Information Apprehensions

Medical aid illustration
The proposed US financial assistance was aimed at programmes for HIV/Aids treatment and prevention, tuberculosis, and malarial diseases.

Zimbabwe has rejected a significant US health deal valued at $367m (£272m) spanning five years because of Washington's request for confidential data.

This move was revealed after a government memo dated December was disclosed, which showed Head of State Emmerson Mnangagwa felt the arrangement was "unbalanced".

A government representative later explained that the United States was demanding access to health data for scientific study and commercial purposes but refused to share the resulting advantages from any future treatments.

"We will now turn to the difficult and regrettable task of winding down our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.

The US Embassy noted the US had provided over $1.9bn for health programmes to Zimbabwe during the past twenty years.

A doctors' association in Zimbabwe has appealed for further talks to reach a deal acceptable to all parties so the country's critical HIV treatment initiative can be sustained.

Wider Background

This development comes after a comparable case in neighbouring Kenya, where a court blocked a related deal with the US following concerns were raised about the security of Kenyans' medical information.

After resuming the presidency recently, US President Donald Trump has reduced overseas assistance and closed the US Agency for International Development (USAID).

USAID had managed aid for the American government, but Trump stated its expenditure was "inefficient" and his administration was seeking government-to-government deals to boost openness and accountability.

As per statements, 16 nations in Africa have to date agreed to these new health pacts, representing more than $18.3bn in new funding.

Details of the Declined Deal

The money for Zimbabwe would have supported "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".

"We believe this cooperation would have delivered immense advantages for the people of Zimbabwe, particularly the 1.2 million currently on antiretroviral therapy via US-supported programmes," Tremont added.

However, official spokesman Nick Mangwana argued the arrangement was "unfair".

"The proposal required Zimbabwe to surrender its biological resources and data for a long time, without any corresponding assurance of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that provided information," he stated.

"Effectively, our nation would supply the raw materials for medical research with no certainty that the resulting innovations would be accessible to our people should a future pandemic arise."

Sovereignty and International Frameworks

Mangwana further said that the American exit from the global health body and its push of one-on-one deals were disrupting frameworks already set up through the global organization.

The spokesperson gave as an example its Pandemic Benefit-Sharing scheme created to manage future global health emergencies.

"This system is designed to ensure that when a country contributes its data, the resulting advantages – such as medicines and cures – are shared equitably, not monopolised exclusively by those with the funds to develop them."

The government's concerns regarding the US deal "should not be misconstrued as hostility towards the US," he added.

"We are open to continued dialogue with our US partners on how subsequent collaboration could be arranged in a manner that honours the sovereignty and interests of both nations."

Health Experts Response

The Zimbabwe College of Public Health Physicians (ZCPHP) stated it recognised the official position, but urged that talks should continue since a large portion of the country's Aids initiatives relied on foreign aid.

"If specific concerns exist, such as those involving data governance or agreement terms, these can frequently be addressed through detailed discussion and mutually agreed protections," it added.

The halted deal underscores the ongoing tensions between accepting crucial foreign assistance and protecting national sovereignty in an increasingly data-driven world.

About the author

Robert Thomas

Sophie van der Meer is a certified nutritionist and wellness coach with over a decade of experience in holistic health.

Vital Connect

Type to search articles.